Enbrel etanercept: Marketed

Interim results from a long-term open label follow-up study of Enbrel monotherapy, in which 420

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE